Annual Shareholders Equity
$286.39 M
-$70.49 M-19.75%
December 31, 2023
Summary
- As of February 7, 2025, CLOV annual stockholders equity is $286.39 million, with the most recent change of -$70.49 million (-19.75%) on December 31, 2023.
- During the last 3 years, CLOV annual shareholders equity has risen by +$903.49 million (+146.41%).
- CLOV annual shareholders equity is now -46.51% below its all-time high of $535.41 million, reached on December 31, 2021.
Performance
CLOV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$342.17 M
+$17.28 M+5.32%
September 30, 2024
Summary
- As of February 7, 2025, CLOV quarterly stockholders equity is $342.17 million, with the most recent change of +$17.28 million (+5.32%) on September 30, 2024.
- Over the past year, CLOV quarterly shareholders equity has increased by +$49.69 million (+16.99%).
- CLOV quarterly shareholders equity is now -41.51% below its all-time high of $585.03 million, reached on March 31, 2021.
Performance
CLOV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CLOV Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.8% | +17.0% |
| 3 y3 years | +146.4% | -4.1% |
| 5 y5 years | +10000.0% | -4.1% |
CLOV Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.5% | at low | -36.1% | +19.5% |
| 5 y | 5-year | -46.5% | +146.4% | -41.5% | +155.4% |
| alltime | all time | -46.5% | +146.4% | -41.5% | +155.4% |
Clover Health Investments Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $342.17 M(+5.3%) |
| Jun 2024 | - | $324.89 M(+11.1%) |
| Mar 2024 | - | $292.47 M(+2.1%) |
| Dec 2023 | $286.39 M(-19.8%) | $286.39 M(-11.0%) |
| Sep 2023 | - | $321.85 M(-2.6%) |
| Jun 2023 | - | $330.57 M(+2.3%) |
| Mar 2023 | - | $323.11 M(-9.5%) |
| Dec 2022 | $356.89 M | $356.89 M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $391.98 M(-8.2%) |
| Jun 2022 | - | $426.92 M(-12.8%) |
| Mar 2022 | - | $489.81 M(-8.5%) |
| Dec 2021 | $535.41 M(-186.8%) | $535.41 M(+31.1%) |
| Sep 2021 | - | $408.39 M(+31.3%) |
| Jun 2021 | - | $310.95 M(-46.8%) |
| Mar 2021 | - | $585.03 M(-194.8%) |
| Dec 2020 | -$617.10 M(>+9900.0%) | -$617.10 M |
| Dec 2019 | -$17.60 K | - |
FAQ
- What is Clover Health Investments annual stockholders equity?
- What is the all time high annual shareholders equity for Clover Health Investments?
- What is Clover Health Investments annual shareholders equity year-on-year change?
- What is Clover Health Investments quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Clover Health Investments?
- What is Clover Health Investments quarterly shareholders equity year-on-year change?
What is Clover Health Investments annual stockholders equity?
The current annual shareholders equity of CLOV is $286.39 M
What is the all time high annual shareholders equity for Clover Health Investments?
Clover Health Investments all-time high annual stockholders equity is $535.41 M
What is Clover Health Investments annual shareholders equity year-on-year change?
Over the past year, CLOV annual stockholders equity has changed by -$70.49 M (-19.75%)
What is Clover Health Investments quarterly stockholders equity?
The current quarterly shareholders equity of CLOV is $342.17 M
What is the all time high quarterly shareholders equity for Clover Health Investments?
Clover Health Investments all-time high quarterly stockholders equity is $585.03 M
What is Clover Health Investments quarterly shareholders equity year-on-year change?
Over the past year, CLOV quarterly stockholders equity has changed by +$49.69 M (+16.99%)